MAXLINEAR, INC·4

May 5, 4:11 PM ET

BEAVER CAROLYN 4

Research Summary

AI-generated summary

Updated

MaxLinear (MXL) Director Carolyn Beaver Sells 6,000 Shares

What Happened
Carolyn Beaver, a director of MaxLinear, converted 15,741 restricted stock units (RSUs) into common shares on May 1, 2026 (recorded as an exercise/conversion of a derivative at $0.00). She then sold 6,000 of those shares in an open-market transaction on May 4, 2026 for a weighted average price of $76.96, generating proceeds of approximately $461,747. The conversion/settlement of the derivative is also reported (derivative disposed at $0.00), reflecting the RSU-to-share settlement.

Key Details

  • Dates and prices:
    • May 1, 2026 — 15,741 RSUs vested and converted to 15,741 shares (exercise/conversion at $0.00). (F2, F3)
    • May 4, 2026 — Sold 6,000 shares in the open market at a weighted average price of $76.96 (range $76.95–$77.03). Proceeds ≈ $461,747. (F1)
  • Shares owned after transaction: Not specified in the provided filing data.
  • Notable footnotes:
    • F1: Weighted average price reported; seller can provide per-price breakdown on request.
    • F2: Each RSU equals one share of MaxLinear common stock.
    • F3: 100% of the RSUs vested on May 1, 2026.
  • Filing timeliness: Form 4 was filed on May 5, 2026; the filing appears to be within the standard two-business-day reporting window for these transactions.

Context
RSUs are a grant that converts into shares when vested — here the RSUs fully vested and were settled into shares on May 1. The later open-market sale on May 4 appears to be a partial disposition of those newly acquired shares. This is a sale (liquidity) event rather than a purchase; such routine insider sales often reflect personal tax or portfolio needs rather than a direct signal about company prospects. There is no indication in the filing of a 10b5-1 plan, gift, or tax-withholding share surrender in the items provided.